2026 NPPES data Ambulatory Care Pharmacist NPI 1770195232 PHARMD
Verify on CMS →

ALEXI SPOTO, PHARMD

Ambulatory Care Pharmacist in SACRAMENTO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
442
Medicare Part D claims · 98 beneficiaries · Ambulatory Care Pharmacist avg: 492
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ALEXI SPOTO, PHARMD filed 442 Medicare Part D claims in 2023 as a Ambulatory Care Pharmacist in SACRAMENTO, California, prescribing 94% generic.

442
Part D claims, 2023
94%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALEXI SPOTO, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

442 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ALEXI SPOTO, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 08/17/2020

NPI 1770195232

Primary specialty

Ambulatory Care Pharmacist

Niche

3,473 US NPIs in this specialty

Medicare Part D claims

442 10% vs specialty avg

2023 prescription claims

Specialty avg: 492

Specialty distribution in California

How Ambulatory Care Pharmacist compares to other specialties among California providers

California providers

Ambulatory Care Pharmacist share within California

1. Ambulatory Care Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ambulatory Care Pharmacist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Ambulatory Care Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ambulatory Care Pharmacist ABMS/AOA estimate

Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALEXI SPOTO, PHARMD appears in the CMS NPPES registry as a Ambulatory Care Pharmacist provider holding PHARMD credentials at 6600 BRUCEVILLE RD, SACRAMENTO, CA, 95823, with a listed phone of (916) 525-6900. NPI 1770195232 was issued on 08/17/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SPOTO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 442 prescription claims written by this provider, covering 98 Medicare beneficiaries and totaling roughly $16K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 10.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,473 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6600 BRUCEVILLE RD
SACRAMENTO, CA 95823

Provider Details

NPI 1770195232
Specialty Ambulatory Care Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 08/17/2020

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ALEXI SPOTO, PHARMD. To verify ALEXI SPOTO, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ALEXI SPOTO, PHARMD — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 442 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

442
Total Claims
$16K
Total Drug Cost
98
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
687
Total Day Supply
20,081
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$7K
Generic Drug Cost
$10K
Opioid Claims
44 (10.0% rate)

Patient Demographics

Average Patient Age
68.1 years
Avg HCC Risk Score
1.55
Gender Split
61% female / 39% male
Age Distribution
<65: 31, 65-74: 37, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALEXI SPOTO, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Pregabalin
103
Duloxetine Hcl
80
Gabapentin
69
Venlafaxine Hcl Er
Venlafaxine Hcl
44
Lidocaine
25
Oxycontin
Oxycodone Hcl
25
Nortriptyline Hcl
20
Clonidine Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ambulatory Care Pharmacist Overview

How ALEXI SPOTO, PHARMD fits within the Ambulatory Care Pharmacist landscape nationally.

3,473
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
492
Avg Claims per Provider

ALEXI SPOTO, PHARMD's 442 claims are below the specialty average of 492.

Nearby Ambulatory Care Pharmacist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SPOTO.

Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALEXI SPOTO, PHARMD's specialty?
ALEXI SPOTO, PHARMD specializes in Ambulatory Care Pharmacist and practices in SACRAMENTO, California. Credentials: PHARMD.
How much does ALEXI SPOTO, PHARMD prescribe under Medicare Part D?
In 2023, ALEXI SPOTO, PHARMD wrote 442 Medicare Part D claims totaling $16K in drug costs for 98 beneficiaries.
Where is ALEXI SPOTO, PHARMD located?
ALEXI SPOTO, PHARMD is located at 6600 BRUCEVILLE RD, SACRAMENTO, CA, 95823. Phone: (916) 525-6900.
What is ALEXI SPOTO, PHARMD's NPI number?
ALEXI SPOTO, PHARMD's National Provider Identifier (NPI) is 1770195232, issued on 08/17/2020.
Does ALEXI SPOTO, PHARMD prescribe more brand-name or generic drugs?
ALEXI SPOTO, PHARMD's prescribing is 6% brand-name and 94% generic drugs by claim count, with $7K in brand drug costs.
Does ALEXI SPOTO, PHARMD prescribe opioids?
Yes, ALEXI SPOTO, PHARMD had 44 opioid claims in 2023 with an opioid prescribing rate of 10.0%.
How many Ambulatory Care Pharmacist providers are there in the US?
There are 3,473 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 492 Medicare Part D claims per year.
What drugs does ALEXI SPOTO, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, ALEXI SPOTO, PHARMD's most frequently prescribed drugs include Pregabalin, Duloxetine Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALEXI SPOTO, PHARMD accept Medicare?
ALEXI SPOTO, PHARMD appears in CMS Medicare data with 442 Part D claims and 98 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALEXI SPOTO, PHARMD's credentials?
ALEXI SPOTO, PHARMD's NPI is 1770195232 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology